Latest News about PFE
Recent news which mentions PFE
Is It Too Late to Buy Pfizer Stock?
April 14, 2023
From Motley Fool
3 Cheap Blue-Chip Stocks to Buy Before They Rocket
April 13, 2023
From InvestorPlace
7 Stocks That Will Surge in a Recession Scenario
April 13, 2023
From InvestorPlace
Ukraine’s prime minister urges U.S. companies to join $411 billion reconstruction effort
April 13, 2023
From MarketWatch
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
April 13, 2023
From Motley Fool
7 Blue-Chip Stocks to Buy for 100% Returns
April 12, 2023
From InvestorPlace
US Court Favors Moderna In COVID-19 Vaccine Patent Infringement Case With Arbutus Biopharma
April 12, 2023
From Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
From Benzinga
From Motley Fool
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
From Benzinga
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
From Benzinga
From Benzinga
Drugmakers Stand Up for Reproductive Rights: Pfizer and Biogen Among 300 Condemning Abortion Pill Approval Suspension
April 11, 2023
From Benzinga
2 Forever Stocks to Buy No Matter What the Market Is Doing
April 11, 2023
From Motley Fool
From Benzinga
5 High-Yield Dividend Stocks in Warren Buffett's Secret Portfolio You Can Buy Right Now
April 10, 2023
From Motley Fool
3 No-Brainer Stocks to Buy in a New Bull Market
April 08, 2023
From Motley Fool
5 Recession-Proof Stocks With High Cash, Low Debt, Strong Dividends To Protect Your Portfolio In 2023
April 07, 2023
From Benzinga
2 Top Biotech Stocks to Buy Right Now
April 07, 2023
From Motley Fool
7 Very Undervalued Penny Stocks to Buy in April 2023
April 06, 2023
From InvestorPlace
From Motley Fool
Is Pfizer Stock a Buy, Sell or Hold? Here’s My Call.
April 06, 2023
From InvestorPlace
From Benzinga
Pfizer's RSV Candidate Shines with 82% Efficacy, Despite Competition in Crowded Field
April 06, 2023
Tickers
PFE
From Benzinga
3 Cheap Dividend Stocks to Buy In April
April 05, 2023
From Motley Fool
Pfizer Slapped With Additional Patent Infringement Lawsuit Over Its Famed COVID-19 Shots
April 04, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.